{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:33:56Z","timestamp":1787610836251,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["113282"],"award-info":[{"award-number":["113282"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-113282"],"award-info":[{"award-number":["TSGH-E-113282"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020953","name":"Taiwan Centers for Disease Control","doi-asserted-by":"publisher","award":["MOHW113-CDC-C-114-144301"],"award-info":[{"award-number":["MOHW113-CDC-C-114-144301"]}],"id":[{"id":"10.13039\/100020953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-016-039"],"award-info":[{"award-number":["112-2314-B-016-039"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-016-016"],"award-info":[{"award-number":["113-2314-B-016-016"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-016-023"],"award-info":[{"award-number":["NSTC 112-2314-B-016-023"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["CMNDMC11206"],"award-info":[{"award-number":["CMNDMC11206"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["CMNDMC11303"],"award-info":[{"award-number":["CMNDMC11303"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["MND-MAB-D-113078"],"award-info":[{"award-number":["MND-MAB-D-113078"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["MND-MAB-D-112115"],"award-info":[{"award-number":["MND-MAB-D-112115"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["IV-113-SP-01"],"award-info":[{"award-number":["IV-113-SP-01"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004699","name":"Chung Shan Medical University Hospital","doi-asserted-by":"publisher","award":["CSH-2024-C-023"],"award-info":[{"award-number":["CSH-2024-C-023"]}],"id":[{"id":"10.13039\/501100004699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jmii.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:12:12Z","timestamp":1738843932000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial resistance among imipenem-non-susceptible Escherichia coli and Klebsiella pneumoniae isolates, with an emphasis on novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations and tetracycline derivatives: The Taiwan surveillance of antimicrobial resistance program, 2020\u20132022"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-082X","authenticated-orcid":false,"given":"Yu-Lin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Eng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0046-5705","authenticated-orcid":false,"given":"Wei-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Fen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Sung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-6450","authenticated-orcid":false,"given":"Shu-Chen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.01.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106633","article-title":"Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections","volume":"60","author":"Kanj","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciy576","article-title":"Ceftazidime\/avibactam, meropenem\/vaborbactam, or both? clinical and formulary considerations","volume":"68","author":"Pogue","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.01.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106528","article-title":"Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment","volume":"59","author":"Lee","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)","volume":"76","author":"Falcone","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.01.006_bib6","first-page":"522","article-title":"New antimicrobial treatment options for severe Gram-negative infections","volume":"28","author":"Hetzler","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jmii.2025.01.006_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01991-21","article-title":"Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed","volume":"66","author":"Butler","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/phar.2782","article-title":"Review of novel \u03b2-lactams and \u03b2-lactam\/\u03b2-lactamase inhibitor combinations with implications for pediatric use","volume":"43","author":"Olney","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2025.01.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112829","article-title":"\u03b2-lactam antibiotics: an overview from a medicinal chemistry perspective","volume":"208","author":"Lima","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jmii.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2022.02.001","article-title":"Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms","volume":"55","author":"Sy","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.01.006_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106679","volume":"60","author":"Lee","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/jac\/dkab141","article-title":"In vitro activity of imipenem\/relebactam, meropenem\/vaborbactam, ceftazidime\/avibactam, cefepime\/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan","volume":"76","author":"Kuo","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib13","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: 30th Informational Supplement M100-S34 CLSI, Wayne, PA, USA","year":"2024"},{"key":"10.1016\/j.jmii.2025.01.006_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01432-20","article-title":"In vitro activity of WCK 5222 (cefepime-zidebactam) against worldwide collected Gram-negative bacilli not susceptible to carbapenems","volume":"64","author":"Karlowsky","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib15","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0. Available at: http:\/\/www.eucast.org. [Accessed June 2024]."},{"key":"10.1016\/j.jmii.2025.01.006_bib16","series-title":"Antibacterial Susceptibility Test Interpretive Criteria","year":"2024"},{"key":"10.1016\/j.jmii.2025.01.006_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad046","article-title":"Changing epidemiology of carbapenemases among carbapenem-resistant Enterobacterales from United States hospitals and the activity of aztreonam-avibactam against contemporary Enterobacterales (2019-2021)","volume":"10","author":"Sader","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2022.10.003","article-title":"Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan","volume":"86","author":"Lee","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/antibiotics10050536","article-title":"Epidemiology of meropenem\/vaborbactam resistance in KPC-producing Klebsiella pneumoniae causing bloodstream infections in northern Italy, 2018","volume":"10","author":"Gaibani","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jmii.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1093\/jac\/dkaa497","article-title":"Role of new antibiotics for KPC-producing Klebsiella pneumoniae","volume":"76","author":"Theuretzbacher","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01443-17","article-title":"Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae","volume":"61","author":"Lomovskaya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/microorganisms9020271","article-title":"Molecular epidemiology and characterization of carbapenem-resistant Klebsiella pneumoniae isolated from urine at a teaching hospital in Taiwan","volume":"9","author":"Lee","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jmii.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/jac\/dkac233","article-title":"Antimicrobial activity of cefepime\/zidebactam (WCK 5222), a \u03b2-lactam\/\u03b2-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19)","volume":"77","author":"Sader","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01854-22","article-title":"In vitro activity of new \u03b2-lactam-\u03b2-lactamase inhibitor combinations and comparators against clinical isolates of Gram-negative bacilli: results from the China Antimicrobial Surveillance Network (CHINET) in 2019","volume":"10","author":"Guo","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2025.01.006_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00072-17","article-title":"WCK 5222 (Cefepime-Zidebactam) Antimicrobial activity against clinical isolates of Gram-negative bacteria collected worldwide in 2015","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01648-19","article-title":"WCK 5222 (Cefepime\/Zidebactam) Pharmacodynamic target analysis against metallo-\u03b2-lactamase producing Enterobacteriaceae in the neutropenic mouse pneumonia model","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.01.006_bib27","article-title":"Emergence of ceftazidime-avibactam resistance through in vivo blaKPC-2 to blaKPC-33 conversion during treatment of ST11 Klebsiella pneumoniae associated infections","volume":"64","author":"Lai","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib28","article-title":"Conversion of blaKPC-2 to blaKPC-33 leads to worldwide emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae","volume":"64","author":"Lai","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04111-23","article-title":"KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97","volume":"12","author":"Sanz","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2025.01.006_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jmii.2022.09.009","article-title":"In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.01.006_bib31","volume":"58","author":"Lee","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106178","article-title":"In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae","volume":"56","author":"Clark","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2147\/IDR.S208231","article-title":"Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015","volume":"12","author":"Chang","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jmii.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2019.06.009","article-title":"Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018","volume":"54","author":"Lee","year":"2019","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:51:40Z","timestamp":1778622700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1684118225000301"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.01.006","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance among imipenem-non-susceptible Escherichia coli and Klebsiella pneumoniae isolates, with an emphasis on novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations and tetracycline derivatives: The Taiwan surveillance of antimicrobial resistance program, 2020\u20132022","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}